Biggest News Aggregation in the World
📰 Overactive Bladder News

Page 168 - Overactive Bladder News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Overactive Bladder. Real-time updates on events, politics, business and more.

Bayer ends work on cough med that passed phase 2b weeks after FDA rejected Merck's drug

Bayer will no longer work on eliapixant, an Evotec-partnered asset that was studied across four indications in midstage tests, including chronic cough. The companies will continue working together on other assets in phase 1, preclinical and discovery stages.
Bristol Myers Squibb Bellus Health Novo Nordisk German Big Pharma Big Pharma Overactive Bladder

Bowel Stimulators Market to witness a 6.3% growth during the year 2022-2031

According to the latest research by Future Market Insights, Bowel Stimulators market is set to witness a 6.3% growth during the year 2021-2031. The market has been developing at a gradual rate and is projected to witness lucrative growth due to increasing number of population suffering from Overactive Bladder (OAB)...
United States Laborie Inc Axonics Inc Indian Journal Of Community Medicine Medicaid Services Future Market Insights

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science